DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Shigesawa T, Suda G, Kimura M. et al.
Baseline angiopoietin-2 and FGF19 levels predict treatment response in patients receiving multikinase inhibitors for hepatocellular carcinoma.
JGH Open 2020;
4 (05) 880-888
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.